Founded in 1994, it is a listed company and an early domestic enterprise engaged in the research, development and production of genetic engineering drugs, and enjoys a good reputation in the fields of industrialized animal cell biopharmaceutical technology and humanized therapeutic monoclonal antibody drug development technology
Anhui Anke Bioengineering (Group) Co., Ltd.,It has long been committed to the research and development of cell engineering products, genetic engineering products, precision medicine and other pharmaceutical and medical technologies and products, and the construction of core technical capabilities, and has established a postdoctoral research workstation, an academician workstation in Anhui Province, and a gene drug engineering technology research center in Anhui Province and Hefei City, which together constitute the company's independent innovation support system.
Anke Biotech is one of the earliest high-tech industries engaged in the research, development and production of genetic engineering drugs in China. The company has leading strength in industrial animal cell biopharmaceutical technology, humanized therapeutic monoclonal antibody drug development technology, long-acting protein drug development technology, and transdermal preparation technology, and has more than 30 invention patents and 5 non-patented technologies.
The company's leading products, recombinant human interferon α2b (Andafin) series preparations, recombinant human growth hormone (Ansumeng), and anti-sperm antibody detection (MAR method) kit (Ansbao) are all independently developed by Anke, with independent intellectual property rights, and the domestic market share ranks within the top five, and is exported to more than 10 countries and regions, and has won the bid for foreign government procurement for many times.
With the overall goal of creating a first-class biomedical enterprise in China, the company has formulated a horizontal integration strategy with biomedicine as the main axis and Chinese and Western medicine and precision medicine as the two wings of "one main and two wings" for coordinated development.
